Holen Sie sich die Stockscreener-App
25.26
3.96%
-1.0152
Schlusskurs vom Vortag:
$26.28
Offen:
$26.21
24-Stunden-Volumen:
807.91K
Relative Volume:
0.31
Marktkapitalisierung:
$3.15B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-238.77M
KGV:
-0.9424
EPS:
-26.808
Netto-Cashflow:
$-216.62M
1W Leistung:
+5.78%
1M Leistung:
+120.43%
6M Leistung:
+557.27%
1J Leistung:
+284.16%
1-Tages-Spanne:
$24.99
$26.27
1-Wochen-Bereich:
$23.18
$27.20
52-Wochen-Spanne:
$2.7601
$27.20
Alumis Inc Stock (ALMS) Company Profile
Firmenname
Alumis Inc
Sektor
Branche
Telefon
650-231-6625
Adresse
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Vergleichen Sie ALMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALMS
Alumis Inc
|
25.29 | 3.28B | 0 | -238.77M | -216.62M | -26.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.63 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.34 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
811.57 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
360.84 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.19 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Alumis Inc Stock (ALMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-21 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-07-25 | Eingeleitet | Wells Fargo | Overweight |
| 2025-06-10 | Fortgesetzt | Guggenheim | Buy |
| 2025-01-30 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-31 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-10-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-23 | Eingeleitet | Guggenheim | Buy |
| 2024-07-23 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-23 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Alumis Inc Aktie (ALMS) Neueste Nachrichten
Alumis (NASDAQ:ALMS) Coverage Initiated by Analysts at Chardan Capital - MarketBeat
This Crescent Biopharma Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Chardan Capital initiates coverage on Alumis stock with Buy rating By Investing.com - Investing.com Nigeria
Chardan Capital initiates coverage on Alumis stock with Buy rating - Investing.com
Alumis (NASDAQ:ALMS) Hits New 12-Month HighWhat's Next? - MarketBeat
Profit Recap: Is now the right time to enter ASTCJuly 2025 WrapUp & Technical Confirmation Alerts - baoquankhu1.vn
Trading Recap: Is Alumis Inc gaining market shareJuly 2025 Market Mood & Growth Focused Entry Point Reports - baoquankhu1.vn
Aug Reactions: What is the long term forecast for XPLR Infrastructure LP Limited Partnership stock - baoquankhu1.vn
Alumis stock reaches all-time high at 25.25 USD By Investing.com - Investing.com India
Top Small Cap Stocks To Watch NowJanuary 6th - MarketBeat
Alumis stock reaches all-time high at 25.25 USD - Investing.com
Aug Weekly: What’s Enterprise Products Partners L.P. Limited Partnership’s historical returnMarket Activity Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib - AOL.com
Huge Insider Buying Now at This Insurance Giant and 2 Biotechs - 24/7 Wall St.
Alumis (ALMS) Is Up 22.0% After Phase 3 Psoriasis Win And $300 Million Equity Raise - Yahoo Finance
HC Wainwright & Co. hikes Alumis Inc. (ALMS)’s price target to $40 from $20, reiterates buy rating - MSN
Alumis (ALMS) price target increased by 79.14% to 36.28 - MSN
An Almus (ALMS) Insider Bought 588,000 Shares for $10.0 Million - AOL.com
Staar Surgical, Alumis, and more stocks see action from activist investors - MSN
Staar Surgical, Alumis, and More Stocks See Action From Activist Investors - Barron's
Russell 2000 Kicks Off 2026 Strong, Surging Over 7% Year-to-Date - Intellectia AI
14 Best Booming Stocks to Buy Right Now - Insider Monkey
HC Wainwright & Co. Hikes Alumis Inc. (ALMS)’s Price Target To $40 From $20, Reiterates Buy Rating - Insider Monkey
Alumis (ALMS) Is Up 35.8% After Psoriasis Data And $300M Raise Has The Bull Case Changed? - simplywall.st
HC Wainwright & Co. Hikes Alumis Inc. (ALMS)'s Price Target To $40 From $20, Reiterates Buy Rating - Finviz
Alumis (ALMS) stock jumps as insider filings show $17 buys — what investors are watching next - TechStock²
Why Alumis Inc. Stock Is Surging Right Now - TipRanks
Alumis (NASDAQ:ALMS) Stock Price Up 6.6% Following Insider Buying Activity - MarketBeat
Alumis' Meteoric Rise To $20 From $5 In Just 60 Days On Plaque Psoriasis Trial Results - RTTNews
Alumis (ALMS) Price Target Increased by 79.14% to 36.28 - Nasdaq
Alumis Inc stock hits all-time high at 22.33 USD By Investing.com - Investing.com Nigeria
Assessing Alumis (ALMS) Valuation After Positive Phase 3 Psoriasis Data And Follow On Equity Offering - simplywall.st
Insider Makes Bold Multimillion-Dollar Bet on Alumis Inc. - TipRanks
Insider Buying: Alumis (NASDAQ:ALMS) Director Purchases 588,235 Shares of Stock - MarketBeat
Aug Sectors: Will Alumis Inc stock benefit from automation2025 Performance Recap & Low Drawdown Momentum Trade Ideas - moha.gov.vn
Akkaraju of Alumis buys shares worth $9.9 million By Investing.com - Investing.com Nigeria
Akkaraju of Alumis buys shares worth $9.9 million - Investing.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Hedge Fund and Insider Trading News: Bill Ackman, Ray Dalio, Warren Buffett, Balyasny Asset Management, Schonfeld Strategic Advisors, Renaissance Technologies, Anson Investments, Limoneira Co (LMNR), Alumis Inc (ALMS), and More - Insider Monkey
Alumis (NASDAQ:ALMS) Reaches New 1-Year High on Insider Buying Activity - MarketBeat
Alumis Inc stock hits all-time high at 22.33 USD - Investing.com
Why Alumis Inc. Stock Is Quietly Surging Higher - TipRanks
Support Test: Is Alumis Inc stock a buy on dipsMarket Activity Summary & Weekly Top Gainers Alerts - Bộ Nội Vụ
Alumis Inc. Stock (ALMS) Opinions on Phase 3 Trial Results - Quiver Quantitative
Latham & Watkins Advises on Alumis’ Upsized US$345 Million Public Offering of Common Stock - Legal Desire Media and Insights
Insider Buying: Alumis (NASDAQ:ALMS) Major Shareholder Buys 411,764 Shares of Stock - MarketBeat
Alumis Insider Bought Shares Worth $6,999,988, According to a Recent SEC Filing - marketscreener.com
Foresite Labs buys Alumis (ALMS) shares worth $7 million By Investing.com - Investing.com Nigeria
Insider Buying: Alumis (NASDAQ:ALMS) Director Acquires 411,764 Shares of Stock - MarketBeat
Foresite Labs buys Alumis (ALMS) shares worth $7 million - Investing.com
Finanzdaten der Alumis Inc-Aktie (ALMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.38%
1.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):